Vildagliptin is a selective, competitive and reversible DPP-4 inhibitor. Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 21 (GLP21) are important hormones that regulate body glucose concentration and have the same functions as intestinal insulin.
Vildagliptin is a potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor synthesized via cyclization of specific amino acid derivatives. Its chemical structure is defined by the molecular formula C12H23N5O and CAS Registry Number 486459-70-3, primarily utilized in the pharmaceutical manufacturing sector.
Strictly adhere to clinical contraindications regarding renal impairment and hypersensitivity reactions. Storage requires maintaining temperatures between 2°C and 8°C in dry, light-resistant containers to ensure chemical stability and prevent degradation.